Built on Science. Designed to Revolutionize.
Management Team
Protocol's highly seasoned professional team with deep experience in medical, science, strategic planning, operations and capital formation.
Steve Bates
Todd Doshier
Ryan Doshier
Patrick Fulbright
Joseph Harker
David Hitt
Whitney North
Dr. Marvin Slepian, M.D.
Florian Strasser
Daniel Strasser
Dr. Jerry Thornthwaite
Dr. Brett Yunker, M.D.
Protocol Technology
Protocol identifies cutting-edge biotechnologies with transformative potential, and turn it into real-world innovation. From proprietary delivery systems to diagnostic breakthroughs, our platform brings bold science to life.
01
TriAntiMal™
Developing treatments for global diseases like malaria through advanced biotechnologies and novel delivery methods.
02
Nutraceuticals
Enhancing absorption, and accessibility of compounds, unlocking more effective formulations across multiple high-nutrition categories.
03
OncoTrak™
Utilizes advanced biomarkers and proprietary immunoassay technologies for early stage disease indicators.
ABOUT Protocol
We exist to incubate bold, science-first technologies, supporting breakthrough ideas through research, testing, and design. Our mission is to transform early-stage innovation into real-world solutions that push industries forward.
